AI Leading the Way to More Precise Diagnostics and Disease Risk Prediction
Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...
Cleerly has launched Cleerly 2.2.0, a new version of its software that includes user experience improvements and three new tools.
By AuntMinnie.com staff writers
February 9, 2022
The new version features a quantitative comparison tool that tracks heart disease by the amount and type of atherosclerosis. The new technology also calculates the percentage of atheroma volume, enabling the quantification of the percentage of the vessel that is full of plaque.
See full article HERE.
Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...
Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...
Nasdaq interviews CEO Dr. James K. Min, one of their 18 “Brilliant Minds in Healthcare,” about Cleerly’s founding, his vision for the company, and...